ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 052

Nasopharyngeal Pneumococcus Colonization in Patients with Childhood Onset Systemic Lupus Erythematosus (cSLE) Compared to Healthy Controls

Fatima Barbar-Smiley1, Stacy Ardoin 2, Chack-Yung Yu 3, Veronica Mruk 4, Cagri Yildirim-Toruner 2, Vidya Sivaraman 5, Joanne Drew 1, alexa meara 6, Asuncion Mejias 2 and Octavio Ramilo 7, 1Nationwide Children's Hospital, Columbus, Ohio, 2Nationwide Children's Hospital, Columbus, 3Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, 4The Ohio State University, Columbus, 5Division of Rheumatology, Nationwide Children's Hospital, Bexley, 6The Ohio State University Wexner Medical Center, COLUMBUS, 7Nationwide Children's Hospital, 700 Children's Drive

Meeting: 2020 Pediatric Rheumatology Symposium

Keywords: childhood lupus, nasopharyneal colonization, pneumococcal vaccine, Systemic lupus erythematosus (SLE), Vaccines

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

The 2020 Pediatric Rheumatology Symposium, originally scheduled for April 29 – May 2, was postponed due to COVID-19; therefore, abstracts were not presented as scheduled.

Date: Thursday, April 30, 2020

Session Title: Poster Session 1

Session Type: ACR Abstract Session

Session Time: 6:00PM-7:00PM

Background/Purpose: Streptococcus pneumoniae (S. pneumoniae) may lead to severe life-threatening infections in both the general and immunocompromised population. Patients diagnosed with Systemic Lupus Erythematosus (SLE) are five times more likely to acquire invasive pneumococcal disease compared to healthy controls. There is a known association between nasopharyngeal (NP) pneumococcal colonization (NPcol) and increased risk of infection with S. pneumoniae. Therefore, the CDC recommends that patients with childhood onset SLE (cSLE) should receive both PCV13 and PPSV23 pneumococcal vaccines. Vaccine effect on pneumococcal NP colonization (VE-col) is suggested as a surrogate marker for protective vaccine effect against invasive pneumococcal infections, especially in young children. To date, no studies have examined the rate of NPcol in cSLE and how it correlates with vaccine immunity in this population. In our pilot study, we are assessing the rate and density of pneumococcal nasopharyngeal colonization following receipt of CDC-recommended pneumococcal vaccination in cSLE patients compared with age-matched healthy controls.

Methods: Case-control study of cSLE patients who have received CDC-recommended pneumococcal vaccines and healthy age-matched controls. Study was approved by local IRB. Participants were consented, study questionnaire provided, then NP swab samples collected and analyzed for quantitative pneumococcal PCR. The positive samples are saved for future study of specific serotypes. Rates of positive NP swabs are compared using chi-square or Fisher’s exact tests. A multivariable logistic regression model will be constructed to determine whether cSLE status is associated with higher likelihood of positive NP swabs while adjusting for possible confounders.

Results: We enrolled 40 cSLE patients and 41 healthy controls (HC). 40 cSLE were of median age 19 years (9y-24y), 31 (78%) females, 22 (55 %) white, 16 (38 %) African American (AA). 41 HC were of median age 19 years (9y-26y), 31 (76%) females, 31 (76 %) white, 2(5 %) African American (AA). NPcol were positive in 2/40 (5%) cSLE and in 0/41 (0%) HC. NPcol identified positive in 1 F (9y) and 1 M (23 y), both diagnosed with lupus nephritis, received immunosuppressive therapy (cyclophosphamide or mycophenolate mofetil and methylprednisolone) during and/or prior to their PCV13 or PPSV23 vaccinations.

Conclusion: Findings of only two positive NP swab sample was not expected as we have anticipated that patients with cSLE will have higher positive rates of NPcol compared to healthy controls. The two cSLE patients with identified positive NPcol were both diagnosed with lupus nephritis and were receiving high dose steroids and cylophosphamide or mycophenolate mofetil surrounding time of vaccination; however, without the PCR serotypes it is difficult to know if this represents vaccine conversion failure. As a next step, we plan to examine pneumococcal serotypes in positive samples to determine if the colonization is related to vaccine-related subtypes. Results of this study will help us better understand indirect markers for immune response to pneumococcal vaccination and to explore factors that may impact the response to pneumococcal vaccine in childhood lupus.


Disclosure: F. Barbar-Smiley, None; S. Ardoin, None; C. Yu, None; V. Mruk, None; C. Yildirim-Toruner, None; V. Sivaraman, None; J. Drew, None; a. meara, None; A. Mejias, Janssen, 1, 2, NIH, 1, Roche, 1, Abbvie, 1; O. Ramilo, Pfizer, 1, 2, NIH, 1, Bill & Melinda Gates Foundation, 1, Janssen, 1, Sanofi/Medimmune, 1, Merck, 1.

To cite this abstract in AMA style:

Barbar-Smiley F, Ardoin S, Yu C, Mruk V, Yildirim-Toruner C, Sivaraman V, Drew J, meara a, Mejias A, Ramilo O. Nasopharyngeal Pneumococcus Colonization in Patients with Childhood Onset Systemic Lupus Erythematosus (cSLE) Compared to Healthy Controls [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 4). https://acrabstracts.org/abstract/nasopharyngeal-pneumococcus-colonization-in-patients-with-childhood-onset-systemic-lupus-erythematosus-csle-compared-to-healthy-controls/. Accessed January 15, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2020 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nasopharyngeal-pneumococcus-colonization-in-patients-with-childhood-onset-systemic-lupus-erythematosus-csle-compared-to-healthy-controls/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.